United Kingdom

Amgen Ltd

Reference: GB-PPON-PDJG-8184-TCQQ

Awards

€1,964,829,127

Total awarded

Recent awards

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
15 June 2026 · £166,347,397
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
15 June 2026 · £665,389,588
Transitional Drugs 7
4 June 2026 · £16,804,001
Ustekinumab
4 June 2026 · £6,532,463
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
1 June 2026 · £18,903,212
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
1 June 2026 · £813,863,584
Transitional Drugs 6
29 January 2026 · £1,637,728
NP49425 Generic and Biosimilar Transition Medicines
Transitional Drugs 7
Transitional Drugs 6

Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.